FUTURE OF HEALTHCARE

Brain Navi Biotechnology Announced Partnership with Distributor, Medtreq Medical Equipment

Brain Navi Biotechnology Co., Ltd. | September 12, 2022 | Read time : 02:00 min

Brain Navi Biotechnology

Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq Medical Equipment, to expand the distribution of the Surgical Navigation Robot, NaoTrac, throughout the region of GCC region, Jordan, Egypt plus other countries in the Middle East and Philippines, Indonesia, Malaysia, and Singapore which will be covered by Medtreq branch in Philippines.

NaoTrac, a CE-certified and local government approval neurosurgical navigation robot from Brain Navi Biotechnology, is embedding dissimilar technology named SMART Technology which combining the machine vision and in-house algorithm to perform robot-assisted surgery, to streamline surgical procedures with real-time imaging and minimal invasive outcomes.

"We are always scouting for the new technology to help as many people as we can. We have many neurosurgeons coming from Riyadh and some other territories keening and willing to learn more about this technology, and the NaoTrac from Brain Navi is one of them. We are always happy to partner with an innovative technology company,"

Sherif Bayoumy, the General Manager of Medtreq Medical Equipment

The collaboration and partnership between Brain Navi and Medtreq enables greater innovative outcome in the Middle East neurosurgery, such as Saudi Arabia, UAE, Egypt, Jordan, and some of the other countries on progressing, to streamline the surgical procedure, improve the surgical accuracy and pass-on knowledge to shorten the learning curves. "We seek strategic partners that can accelerate Brain Navi's growth mission. This partnership is a significant step toward scaling our business and getting more robot-assisted neurosurgery into the world," said Jerry Chen, the CEO of Brian Navi Biotechnology. "The collaboration between Metreq and Brain Navi is looking positive because we share the same mission to innovate with technology to make the life bright. We truly believe that the collaboration between Brain Navi and Medtreq can maximum the value of both sides to bring the neurosurgery to the next level."

About Metreq Medical Equipment Bahrain
Medtreq Medical Equipment provides professional technical support and after-service to clients in the MENA region with a presence in Bahrain and GCC, Egypt, North Africa, Turkey, Europe, the United States (Medtreq Tenessee USA), and the Philippines, Singapore, Malaysia, and Indonesia. Medtreq is built on high values, principles, and social commitment to society and humanity.

About Brain Navi
Brain Navi Biotechnology is a leading Taiwanese surgical robotic company. We design and develop innovative navigation and robotic surgery technologies for surgeons to improve surgical accuracy. Brain Navi's exclusive Surface Mapping Auto-registration Technology (SMART) is a significant surgical robotic breakthrough that merges machine vision, robotics, and AI technology to achieve streamlined surgical procedures with real-time imaging and minimal invasive outcomes.

Spotlight

Dr. William Mohr and Dr. David Alhrenholz, Co-directors at the Burn Center, and Sarah Bazey, Burn Center survivor, introduce Regions Hospital Burn Center. The Burn Center, built in 1963 to care for burn patients full-time, is setting worldwide standards in burn care and is on the cusp of all the burn care advancements. The program at the Burn Center aims to provide patients with a functional and cosmetic appearance and to return them to their pre-injured state as quickly as possible. 85 percent of all Burn Center patients return to home or work.

Spotlight

Dr. William Mohr and Dr. David Alhrenholz, Co-directors at the Burn Center, and Sarah Bazey, Burn Center survivor, introduce Regions Hospital Burn Center. The Burn Center, built in 1963 to care for burn patients full-time, is setting worldwide standards in burn care and is on the cusp of all the burn care advancements. The program at the Burn Center aims to provide patients with a functional and cosmetic appearance and to return them to their pre-injured state as quickly as possible. 85 percent of all Burn Center patients return to home or work.

Related News

HEALTH TECHNOLOGY

GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity

GE Healthcare | November 18, 2022

GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients site in Lindesnes, Norway. The investmentwhich is creating around 100 new jobs – is part of GE Healthcare’s broader commitment to address significant future global demand for iodinated contrast media, used in Xray and Computed Tomography procedures around the world to enhance visualization of organs, blood vessels and tissues across disease pathways. Iohexol and iodixanol API are used in over 100 million patient doses of GE iodinated contrast media annually, equivalent to three patient procedures every second. This new investment, coupled with the recent opening of a new production line at GE Healthcare’s Cork, Ireland, fill and finish facility, aims to enable the production of 30 million more patient doses per year by 2025. “We expect global demand for iodinated contrast media to double in the next 10 years, driven by global prevalence of chronic disorders and significant growth in CT procedures. This investment in capacity expansion at our Lindesnes facility is another example of how we, as an industry leader, are addressing this growing demand to meet the needs of our customers and their patients across the globe.” President & CEO of GE Healthcare Pharmaceutical Diagnostics, Kevin O’Neill The 100-acre Lindesnes site in southern Norway, has been operating since 1974 and employs 450 people, who use multiple chemical pharmaceutical processes to convert iodine into finished API. Recently, GE Healthcare announced a multi-year agreement with SQM, a Chile-based mining company, to secure increasing supply of iodine, the key ingredient in iodinated contrast media. GE Healthcare is the world’s leading supplier of contrast media, used to support patient imaging procedures in 130+ countries globally. All stages of its contrast media manufacturing, from development of Active Pharmaceutical Ingredient (API) to finished product, are managed entirely by GE Healthcare, adhering to current Good Manufacturing Practices. With over 4000 employees globally and seven manufacturing sites, the Pharmaceutical Diagnostics business also develops and supplies radiopharmaceuticals used to support diagnosis, monitoring and treatment selection across Neurology, Cardiology and Oncology clinical pathways. About GE Healthcare GE Healthcare is the $17.7 billion healthcare business of GE. As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Read More

HEALTH TECHNOLOGY

WELL Health to Acquire EMR, Billing and Clinical Assets from CloudMD

WELL Health Technologies Corp. | October 12, 2022

WELL Health Technologies Corp. a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce it has entered into an agreement to acquire Cloud Practice Inc. and three clinics from CloudMD Software & Services Inc. "This transaction demonstrates our dedication to expanding and strengthening WELL's Canadian healthcare offering through disciplined capital allocation. This acquisition will also enable our EMR and billing divisions to enter new markets in the Canadian Prairies where we look forward to supporting healthcare practitioners' access to new digital health innovations." Hamed Shahbazi, CEO and Founder of WELL Cloud Practice is a medical software application company with products including Juno EMR, a cloud based EMR solution based on OSCAR1, and ClinicAid, a medical billing software used by healthcare practitioners who don't need access to a full EMR. Outside of WELL who is the largest provider of OSCAR1 EMR products and services, Juno EMR represented the largest remaining asset and market share available in the OSCAR1 based EMR industry. Both Juno EMR and ClinicAid represent WELL's entrance into the Alberta and Saskatchewan markets for its EMR and medical billing related lines of business. Both assets will be integrated into WELL's Provider Solutions Business Unit, under WELL's existing EMR and Billing platforms. Amir Javidan, COO of WELL commented, "This transaction is a win for healthcare practitioners and their patients as it will allow software users and clinicians joining our network to have access to WELL's innovative Apps.Health platform which includes dozens of apps designed by leading 3rd party digital health companies providing advanced physician tools such as an AI-powered virtual assistant to premium digital patient engagement tools that can drive significant operating efficiencies for clinics." The three primary care clinics being acquired in the Transaction currently have a total staff of 20 physicians operating out of two clinics in Vancouver, BC and one clinic in Surrey, BC. These clinics are owned by subsidiaries of CloudMD, with all of the shares of these entities being acquired as part of the Transaction. These three clinics will be integrated into WELL's existing primary care clinic network under WELL Health Canada Clinics Inc. About WELL Health Technologies Corp. WELL is a practitioner focused digital healthcare company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient services offerings. As such, WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on OTCQX under the symbol "WHTCF".

Read More

HEALTH TECHNOLOGY

Advantage Healthcare Partners with Spencer Health Solutions to Improve Outcomes for Behavioral Health Patients Enrolled in Pharma Support Programs

Advantage Healthcare Services and Spencer Health Solutions | September 26, 2022

Spencer Health Solutions a digital health company based in North Carolina’s Research Triangle Park, announced that Advantage Healthcare Services, a leading provider of mental health pharmacy support for the state of California, has joined its Certified Pharmacy Partner Network to offer enhanced, in-home patient services for one of its largest commercial pharmaceutical programs. As part of the Spencer-Certified Pharmacy Partner Network, Advantage Health will work cooperatively with SHS, pharmaceutical manufacturers, payers, and healthcare systems on large-scale, post-approval monitoring sponsored by pharmaceutical companies that provide in-home support for patients living with severe and persistent behavioral health conditions. “Our proactive approach to patient attention and care enables us to be with a patient during all aspects of their treatment and therapies. Participating in Spencer Health Solutions’ commercial pharmacy programs, and using the spencer® patient support platform, fits perfectly with our mission to work closely with a patient and their medical team to consult, observe, and intervene when the need arises for complete collaborative healthcare.” Nevil Jhaveri, Chief Technology Officer at Advantage Healthcare Services The spencer smart hub collects longitudinal insights from patients that can be leveraged to generate patient interventional support strategies. The smart hub is an FDA-certified Class 1 medical device that is easy to set up and use, only requiring the patient to plug it in and place a refill pack of medicines inside. The device connects to the Internet through an integrated cellular network or the user’s Wi-Fi network to quickly and securely Alert patients to take their pre-packaged medications on a prescribed schedule Dispense medications and document medication adherence. Gain greater patient access with integrated, secure telehealth services within the platform Automatically integrate data from in-home wearable, biometric devices. “We feel fortunate to partner with Advantage and contribute to their long-standing reputation for thinking outside the box in support of their patients,” said Tom Rhoads, founder and CEO of Spencer Health Solutions. “Having spencer in patients’ homes will significantly improve health outcomes for this high-risk population that struggles with medication adherence and engagement.” Spencer Health Solutions is exhibiting its spencer smart hub and pouch technology at the upcoming National Association of Specialty Pharmacists (NASP) 2022 Annual Meeting and Expo, and has been invited to present at the event’s Technology Day Innovation Lab on September 19th. Spencer Health Solutions invites NASP event attendees to join them for the unique one-day workshop, or to schedule a time for a personal, on-site demo. About Advantage Healthcare Services Advantage Healthcare Services’ core mission is to create solutions that support patients through the care continuum and aid in improving health outcomes. Based in California, Advantage specializes in crafting tailored solutions that bridge medication access and adherence impasses. With a primary focus of serving patients suffering from behavioral and mental health disorders, the company takes a consulting approach to developing sustainable solutions for the private practice sector, as well as for state- and county-funded programs. Through the utilization of an in-house data and analytics team, Advantage produces actionable reporting tools to identify at-risk patients, enabling caretakers to proactively intervene, improve health outcomes, and reduce rehospitalizations. About Spencer Health Solutions Spencer Health Solutions is a digital health technology provider dedicated to improving patient engagement and medication adherence for clinical trials and commercial pharmaceutical programs. Headquartered in North Carolina’s Research Triangle Park, Spencer Health Solutions’ award-winning spencer® smart hub provides near real-time monitoring of patients’ behaviors and Rx patterns that result in improved persistency, improved patient retention, and more positive health outcomes.

Read More